NCT06433427View on ClinicalTrials.gov

Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction

Not yet recruitingOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

May 29, 2024

Primary Completion Date

May 30, 2025

Study Completion Date

February 22, 2026

Conditions
AgingFrailtyMitochondrial DysfunctionChronic Disease
All Listed Sponsors
collaborator

University of Milano Bicocca

OTHER

lead

University Hospital of Ferrara

OTHER

NCT06433427 - Metabolic Dysregulation as Biomarker of Frailty: Role of the Mitochondrial Dysfunction | Biotech Hunter | Biotech Hunter